Evolving FDA Thinking on Advisory Committee Meetings Related to Foods, Drugs, and Devices
FDA advisory committee meetings are important regulatory events for many manufacturers on the path to marketing approval. These meetings can quite literally result in the approval or rejection of a product based on the panel’s vote. Not surprisingly, investors highly scrutinize these proceedings and stock markets react accordingly. For these reasons, it is critical for companies to have a clear understanding of FDA’s thinking related to these meetings.
View
Jun 25, 2020
